Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.

Blood Adv · 2022 · PMC9661433 · PMID 36150047

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although differences between treatment cohorts did not reach statistical significance, this is not unexpected because of the small sample sizes.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.